Dr. Reddy’s Laboratories has refuted media reports alleging a 25% reduction in workforce costs. The Hyderabad-based pharmaceutical giant dismissed claims of layoffs targeting high-earning employees and voluntary retirement offers for older staff, particularly in R&D. Post navigation Wall Street rallies as tech stocks surge on temporary tariff exemptions Nvidia to manufacture AI supercomputer chips entirely in US for first time
